Peanut Product Recall Spurs Six In Ten Americans To Take Steps To Reduce Risk Of Sickness (Medical News Today)
Many mistakenly believe recall involves national brands of peanut butter and are not aware of the range of products involved A new national survey conducted by the Harvard Opinion Research Program at the Harvard School of Public Health finds that the vast majority (93%) of Americans have heard or read about the recent ongoing recall of peanut products.

Oral Laquinimod For Multiple Sclerosis Granted Fast Track Status By FDA (Medical News Today)
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) and Active Biotech (NASDAQ OMX NORDIC: ACTI) today announced that oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis (RRMS), has received a Fast Track designation from the U.S. Food and Drug Administration (FDA).

DeLauro Seeks Info From FDA Amid Political Influence Concerns (Nasdaq)
WASHINGTON -(Dow Jones)- Congresswoman Rep. Rosa DeLauro, concerned about political influence in device and drug approvals, wants details about what products the Food and Drug Administration has approved in the last several months.